Loading...

Home
ETF
CTSO

CTSO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CTSO News

CytoSorbents Announces Q4 and Full Year 2025 Earnings Release Date

5d agoPRnewswire

CytoSorbents (CTSO) Projects $37M Revenue for 2025, FDA Meeting Scheduled

Jan 12 2026PRnewswire

CytoSorbents Reports $37M in Q3 Sales; CEO to Join Virtual Discussion

Dec 10 2025PRnewswire

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

Nov 17 2025PRnewswire

HC Wainwright & Co. Upholds Neutral Rating for Cytosorbents (CTSO)

Nov 15 2025NASDAQ.COM

CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 13 2025PRnewswire

CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

Nov 11 2025PRnewswire

In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

Oct 28 2025PRnewswire

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

Sep 29 2025PRnewswire

CytoSorbents Provides Regulatory Update on DrugSorb-ATR and Intends to Submit New De Novo Application

Sep 16 2025NASDAQ.COM

CytoSorbents Provides DrugSorb-ATR Regulatory Update

Sep 16 2025PRnewswire

CytoSorbents to Present Global Webinar on "Transforming Sepsis and Septic Shock: Practical Insights with CytoSorb" in Honor of World Sepsis Day

Sep 08 2025Newsfilter

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

Sep 08 2025PRnewswire

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 05 2025PRnewswire

Rocket Pharmaceuticals Shares Surge Over 15%; Check Out 20 Stocks Making Moves in Premarket Trading

Aug 20 2025Benzinga

CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

Aug 20 2025PRnewswire